Bebtelovimab is designed as a treatment option for those newly diagnosed with COVID-19 who cannot take Paxlovid and are deemed at high risk of severe outcomes. It replaces a series of monoclonal treatments that no longer are effective against virus due to mutation.
The Minnesota Department of Health said the two variants have become more dominant in the state, thoughs the variants have grown, the number of COVID-19 cases in Minnesota has continued to trend downward since mid-May. Those numbers could be deceiving, however.
A seemingly endless stream of “subvariants” of omicron, the most recent Greek-letter variant, has emerged in the past few months. How different are these subvariants from one another? Can infection by one subvariant protect someone from infection by another subvariant? And how well are the existing coronavirus vaccines doing against the subvariants? We asked medical and epidemiological experts these and other questions.
The pace of COVID-19 transmission continued to decline in North Dakota over the last week, though specifics on the virus' prevalence in the state are thinner since the Department of Health scaled back its updates.
Federal health officials say the best prevention against COVID-19 infection among infants, who cannot be vaccinated, is for pregnant women and new mothers to become vaccinated.
The BA.2 subvariant has been found in most states, according to the Centers for Disease Control and Prevention and accounts for nearly 4% of cases nationwide.
Modeling scientists say cases and hospitalizations now in decline, but have a long way to go. With 1 in 4 residents already infected, the state could see up to 1 in every 2 Minnesotans having been infected by mid-March.
The proposal, made by the WHO's working group on sustainable financing, would increase each member state's standing annual contribution, according to a WHO document published online and dated Jan. 4.
January 22, 2022 01:26 PM
·
By Francesco Guarascio, Trevor Hunnicutt and Stephanie Nebehay / Reuters
"The sheer incompetence, cowardice, and corruption in our response to COVID-19 are proof that we as a country went down the wrong rabbit hole," InForum columnist Ross Nelson writes.
When given early, lab-engineered antibody infusions have reduced COVID-19 hospitalizations among persons at high risk. Previous versions of these treatments do not appear to work against the omicron variant, however. Replacement products are in short supply, with providers given a few dozen treatments weekly while managing hundreds of new patients.
